Teleflex Q4 revenues up 6%, EPS up 39%

• Teleflex (NYSE:TFX) Q4 results ($M): Revenues: 476.0 (+5.7%); Vascular North America: 68.7 (+9.7%); Anesthesia/Respiratory North America: 58.2 (0.7%); Surgical North America: 40.8 (+8.8%); EMEA: 146.9 (+1.4%); Asia: 63.6 (+7.6%); OEM: 35.0 (+2.6%); Operating Income: 52.1 (+30.6%); Net Income: 50.9 (+45.0%); EPS: 1.07 (+39.0%); Quick Assets: 303.2 (-29.8%); CF Ops (12 mo.): 290.2 (+25.5%).
• 2015 Guidance: Revenue Growth: 4 - 6%; Non-GAAP EPS: $6.10 - 6.35.